Galderma Research & Development, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$1.8M
Doctors Paid
59
Transactions
808
2023 Total
$1.1M
Payment Breakdown by Category
Research$1.6M (90.0%)
Consulting$176,040 (10.0%)
Food & Beverage$183.93 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.6M | 750 | 90.0% |
| Consulting Fee | $176,040 | 55 | 10.0% |
| Food and Beverage | $183.93 | 3 | 0.0% |
Payments by Type
Research
$1.6M
750 transactions
General
$176,224
58 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A MULTI-CENTER STUDY TO EVALUATE SUBJECT REPORTED OUTCOMES WITH USE OF TRIFAROTENE 50 MCG/G CREAM IN THE TREATMENT OF MODERATE FACIAL AND TRUNCAL ACNE VULGARIS | $430,909 | 0 | 375 |
| Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 g/g Cream Versus Vehicle Cream Over 24 Weeks | $286,148 | 0 | 53 |
| A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis | $248,038 | 7 | 82 |
| A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO COMPARE EFFICACY AND SAFETY OF TRIFAROTENE (CD5789) CREAM WHEN USED WITH AN ORAL ANTIBIOTIC FOR THE TREATMENT OF SEVERE ACNE VULGARIS | $224,384 | 0 | 59 |
| A Double-Blind, Placebo-Controlled, Randomized Study to Assess the Durability of Effect and Safety of Nemolizumab for 24 Weeks in Subjects With Prurigo Nodularis | $150,398 | 4 | 102 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis | $148,514 | 7 | 21 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis | $83,585 | 4 | 48 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab | $17,567 | 4 | 10 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Dermatology | $206,194 | 28 | $7,364 |
| Pulmonary Disease | $38,670 | 3 | $12,890 |
| Allergy & Immunology | $24,084 | 3 | $8,028 |
| Infectious Disease | $22,083 | 1 | $22,083 |
| Otolaryngology | $14,936 | 6 | $2,489 |
| Internal Medicine | $12,750 | 1 | $12,750 |
| Procedural Dermatology | $12,633 | 4 | $3,158 |
| Pediatrics | $8,550 | 1 | $8,550 |
| Transplant Hepatology | $6,715 | 1 | $6,715 |
| MOHS-Micrographic Surgery | $6,260 | 2 | $3,130 |
| Ophthalmology | $5,731 | 2 | $2,866 |
| Specialist | $3,211 | 2 | $1,606 |
| Dermatopathology | $3,150 | 1 | $3,150 |
| Emergency Medicine | $2,975 | 1 | $2,975 |
| Clinical & Laboratory Dermatological Immunology | $2,370 | 1 | $2,370 |
| Plastic and Reconstructive Surgery | $1,488 | 1 | $1,488 |
| Plastic Surgery within the Head & Neck | $61.31 | 1 | $61.31 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. Michael Bukhalo, Md, MD | Dermatology | Rolling Meadows, IL | $55,963 | $0 |
| Dr. Navid Nami, D.o, D.O | Dermatology | Newport Beach, CA | $28,745 | $0 |
| William Petri, M.d, M.D | Infectious Disease | Charlottesville, VA | $22,083 | $0 |
| Robert Wise, M.d, M.D | Pulmonary Disease | Baltimore, MD | $19,275 | $0 |
| Dr. Anthony Gaspari, M.d, M.D | Dermatology | Baltimore, MD | $16,750 | $0 |
| Dr. Shawn Kwatra, M.d, M.D | Internal Medicine | Baltimore, MD | $12,750 | $0 |
| Janine Vintch, M.d, M.D | Pulmonary Disease | Torrance, CA | $12,645 | $0 |
| Ronald Gottschalk, Md, MD | Dermatology | North Richland Hills, TX | $11,500 | $0 |
| Dr. Naiem Issa, M.d., Ph.d, M.D., PH.D | Dermatology | Vienna, VA | $11,475 | $0 |
| Dr. Paul Shapero, Md, MD | Allergy & Immunology | Bangor, ME | $11,450 | $0 |
| Stephen Peters, Md, MD | Allergy & Immunology | Winston Salem, NC | $9,733 | $0 |
| Mrs. Amy Paller, Md, MD | Pediatrics | Chicago, IL | $8,550 | $0 |
| Leon Kircik, Md, MD | Dermatology | Lousiville, KY | $8,000 | $0 |
| Dr. William Stringer, M.d, M.D | Pulmonary Disease | Torrance, CA | $6,750 | $0 |
| Dr. Brian Kim, M.d, M.D | Transplant Hepatology | Los Angeles, CA | $6,715 | $0 |
| Dr. Natasha Mesinkovska, M.d. Ph.d, M.D. PH.D | Dermatology | Mission Viejo, CA | $4,250 | $0 |
| Dr. Kavita Mariwalla, M.d, M.D | Dermatology | West Islip, NY | $4,180 | $0 |
| Mona Shahriari | Dermatology | Cromwell, CT | $4,100 | $0 |
| Dr. Sabrina Fabi, M.d, M.D | Dermatology | San Diego, CA | $4,000 | $0 |
| Abel Jarell, Md, MD | Dermatology | Portsmouth, NH | $3,950 | $0 |
| Andrew Alexis, Md, MD | Dermatology | New York, NY | $3,950 | $0 |
| Jennifer Soung, M.d, M.D | Dermatology | Santa Ana, CA | $3,950 | $0 |
| Dr. Robert Kalb, Md, MD | Dermatology | Williamsville, NY | $3,693 | $0 |
| Dr. Benjamin Lockshin, Md, MD | Dermatology | Silver Spring, MD | $3,610 | $0 |
| Rebecca Fitzgerald, M.d, M.D | Dermatology | Los Angeles, CA | $3,600 | $0 |
Ad
Top Products
- AKLIEF $952,141
- TRI-LUMA $800.00
Payment Categories
- Food & Beverage $183.93
- Consulting $176,040
- Research $1.6M
About Galderma Research & Development, LLC
Galderma Research & Development, LLC has made $1.8M in payments to 59 healthcare providers, recorded across 808 transactions in the CMS Open Payments database. In 2023, the company paid $1.1M. The top product by payment volume is AKLIEF ($952,141).
Payments were distributed across 17 medical specialties. The top specialty by payment amount is Dermatology ($206,194 to 28 doctors).
Payment categories include: Food & Beverage ($183.93), Consulting ($176,040), Research ($1.6M).